VANCOUVER, June 14, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that communications and government relations expert Jessica Martin will join Invictus as Vice President, Public Relations and Regulatory Affairs, effective July 2, 2018.

As former Press Secretary and Senior Advisor to Ontario's Minister of Finance, Jessica led the development and execution of Ontario's communications strategy for cannabis legalization, participated in excise tax negotiations at Federal, Provincial, and Territorial Finance Ministers meetings in Ottawa, and worked with the Liquor Control Board of Ontario (LCBO) to deliver the branding and retail model for Ontario Cannabis Stores. Her responsibilities will include serving as spokesperson and senior communications lead on major projects and public disclosures, working with our Licensed Producers to develop and execute the Company's retail and distribution strategy, liaising with provincial governments and providing review and commentary on changes in the regulatory environment.

"Jessica Martin has been on the inside of cannabis legalization in Ontario since its inception, working with federal, provincial and municipal governments on a safe and sensible framework for distribution," said Invictus Chairman and CEO Dan Kriznic. "Jessica's thorough understanding of the strict regulatory environment around cannabis legalization, combined with her extensive media network, will provide exceptional value for Invictus as we look to build our brand."

"I am thrilled to join the dynamic and inspired team of professionals at Invictus who are becoming global leaders in the cannabis industry" said Jessica. "Invictus has an impressive portfolio of high-quality products that will tantalize customers and investors alike."

Jessica Martin brings a broad range of experience in media relations, issues management, government relations and digital media. In addition to her work with the Ontario Minister of Finance and LCBO on cannabis legalization she has held a number of high-profile roles, including spokesperson for Toronto Hydro and the Toronto Transit Commission, where she provided live updates on City TV's Breakfast Television, CP24 and 680News. Behind the scenes, Jessica has worked as a Research Analyst at Queen's Park and Floor Director at City TV.

About Invictus

Invictus owns and operates two cannabis production facilities, both with sales licenses, under the ACMPR in Canada, with the vision of producing a variety of high quality and low-cost cannabis products to the global market, as regulations permit. The Company's wholly owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), is located in West-Central Alberta. Invictus also owns 50% of AB Laboratories Inc. ("AB Labs") located in Hamilton, Ontario. AB Ventures Inc. ("AB Ventures") owns 100 acres of land near Hamilton, Ontario, to be used for future cannabis cultivation. Recently, the Company announced that it has entered into a binding letter of intent for an option to acquire 100% of the outstanding shares of an applicant (the "OptionCo") under the ACMPR.

Combined, the licensed producers owned by Invictus expect to have approximately 332,000 square feet of cannabis production capacity by the end of 2018 and 822,000 square feet of cannabis production capacity by the end of 2019.

Gene Simmons, music legend and media mogul, conveys the vision of Invictus as the Chief Evangelist Officer.

Invictus owns 100% of Poda Technologies Ltd. ("Poda") and its related intellectual property, the world's first zero-cleaning vaporizer system. Poda's fully biodegradable pods are self-contained, and do not contaminate the vaporizer with odor, flavor or residue.

In addition to the above, the Company has an 82.5% investment in Future Harvest Development Ltd. ("Future Harvest") a high-quality Fertilizer and Nutrients manufacturer, based in Kelowna, British Columbia, that has been in operation for over 20 years under the brand Plant Life Products and Holland Secret.

Invictus' Canadian Production Footprint:







Square Footage Company Phase Province Current 31-Dec-18 31-Dec-19 Acreage Pharms 1 Alberta 7,000 7,000 7,000 Acreage Pharms 2 Alberta 33,000 33,000 33,000 Acreage Pharms 3 Alberta

80,000 80,000 Acreage Pharms 4 Alberta



240,000 Total Acreage Pharms



40,000 120,000 360,000 AB Laboratories 1 Ontario 16,000 16,000 16,000 AB Laboratories 2 Ontario

40,000 40,000 Total AB Laboratories



16,000 56,000 56,000 AB Ventures 1 Ontario

21,000 21,000 AB Ventures 2 Ontario

80,000 80,000 Total AB Ventures



- 101,000 101,000 Option Co 1 British Columbia

55,000 55,000 Option Co 2 British Columbia



250,000 Total Option Co



- 55,000 305,000 Total Combined

56,000 332,000 822,000

For more information, please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

Larry Heinzlmeir

Vice President, Marketing & Communications

604-537-8676

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including the potential acquisition of OptionCo, and the potential production capacity of OptionCo, AB Labs, AB Ventures and Acreage Pharms, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the Company will be successful in exercising its option to acquire OptionCo including obtaining TSX Venture Exchange approval of the acquisition, that OptionCo and AB Labs will be successful in reaching their potential production capacity, OptionCo, AB Ventures and Acreage Pharms' production facilities will be completed as anticipated, regulatory approval will be granted as anticipated, OptionCo and AB Labs will reach full production capacity on the timeline anticipated by the Company, OptionCo will be granted its first and second licenses, AB Labs will be granted its secondary license on the terms and timeline anticipated by the Company, no unforeseen construction delays will be experienced, and OptionCo and Acreage Pharms will be granted its sales license under the ACMPR on the terms and timeline anticipated by the Company,. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the Company will not complete the acquisition of OptionCo, OptionCo and AB Labs will not be successful in reaching its potential production capacity, OptionCo, AB Ventures and Acreage Pharms' production facilities will not be completed as anticipated, construction delays, regulatory approval will not be granted as anticipated and therefore, the anticipated timing of OptionCo and AB Labs reaching full production capacity will be delayed, AB Labs will not be granted their secondary license, OptionCo will not be granted its first and second licenses and OptionCo and Acreage Pharms will not be granted its sales license under the ACMPR, and licenses or approvals being granted on terms or timelines that are materially worse than expected by the Company. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Invictus MD Strategies